What type of study is this?

October 2, 2025Düzce Tıp Fakültesi DergisiOpen Access

New Parameters That May Predict Tumor Regression and Survival in Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

View Full Paper

Ask AI

Bookmark

Authors

MBMehmet Emin BüyükbayramIstanbul Bilim University ZHZekeriya HannariciSağlık Bilimleri Üniversitesi ATAykut TurhanSağlık Bilimleri Üniversitesi

Discussion

Member takes

Implication

Analysis reveals potential predictors like systemic immune-inflammation index and prognostic nutritional index in locally advanced rectal cancer treatment outcomes.

Key Points

An increase in systemic immune-inflammation index correlates with disease-free survival in patients undergoing neoadjuvant chemoradiotherapy.
Data from 57 patients indicated that 91.2% had adenocarcinoma, with a notable number achieving poor response rates to treatment.
Retrospective analysis of treatment parameters shows the need for further investigation into novel parameters such as the RLR.
Findings highlight the complexity of predicting treatment response in locally advanced rectal cancer, emphasizing the need for additional studies.

Cite This Study

Büyükbayram et al. (2025) studied this question.

synapsesocial.com/papers/68de6f3f83cbc991d0a22ad5 https://doi.org/10.18678/dtfd.1637275

View Full Paper

Ask AI

Bookmark

Implication

Analysis reveals potential predictors like systemic immune-inflammation index and prognostic nutritional index in locally advanced rectal cancer treatment outcomes.

New Parameters That May Predict Tumor Regression and Survival in Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

New Parameters That May Predict Tumor Regression and Survival in Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider